Clinical trial

Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction

NCT01936896

Study summary

ClinicalTrials.gov

Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Alpha 1-Antitrypsin Normalized identity: alpha 1-antitrypsin View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-12-01

PhasePHASE1 / PHASE2

Conditions

Acute Myocardial Infarctionverified · MONDO: acute myocardial infarction

Interventions

Alpha 1-AntitrypsinDRUG · verified · RxNorm: alpha 1-antitrypsin

Sponsors & collaborators

Virginia Commonwealth Universitylead sponsor

Mapped research locations

RichmondVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01936896 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.